suMMARY Body potassium status of patients with cardiac failure may be estimated by a number o methods, but increasing reliance is being placed upon radioisotope dilution with 42K which measures the total exchangeable potassium. Total exchangeable potassium comprises between 86 per cent and 97 per cent of whole body potassium in healthy subjects. We have measured total exchangeable potassium in 22 oedema-free elderly patients with stable cardiac failure and compared the results with simultaneously determined measurements of whole body potassium obtained by whole body counting. The mean whole body potassium was 2360 ±640 mmol. The mean value of total exchangeable potassium measured at 24 hours was 1820 +610 mmol (77% of whole body potassium) and increased further to 2000±600 mmol (84%) when measured after 48 hours. In patients with cardiac failure and, perhaps, also other patients with a history of fluid retention, the mixing of a tracer dose may be significantly delayed, which if not appreciated may lead to an overestimate of potassium depletion.
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A number of studies (White et al., 1969; Davidson and Gillebrand, 1973; Nicholls et al., 1976) reported in the past decade have suggested that potassium depletion is common in patients with cardiac failure.
A recent review (British Medical Journal, 1977) emphasised that elderlypatients should be considered to be especially at risk because of poor dietary intake of potassium, and concluded that potassium supplementation is mandatory for elderly patients in heart failure, particularly those taking long-term diuretics. In all these studies body potassium status has been estimated from measurements of the total exchangeable potassium obtained by radioisotope dilution using 42K or 43K. These studies have suggested an average deficit of potassium content in cardiac failure of approximately 30 per cent. The reference values (especially pre-morbid, predicted, or actual body weights) used in these studies have not been uniform and it may well be that differences in estimated depletion are related to these factors. In general, the measurements are based on spot urine samples taken at hourly intervals from 24 hours after administration of the isotope. In only one case (Novak and Harrison, 1973) were samples taken as late as 36 hours. The radioisotope dilution method requires that equilibration should have occurred between the body otassium and the tracer; in healthy subjects this occurs in 24 hours (Corsa et al., 1950) . However, since 1957 there have been a number of papers suggesting that in certain clinical conditions equilibration may be significantly delayed. O'Meara et al. (1957) suggested that this occurred in patients with fluid retention. Boddy et al. (1972b) investigated patients with chronic renal failure. By using the longer half-life isotope 43K and taking samples up to 64 hours after giving the tracer, they found that equilibration was significantly delayed. The same group of workers (Boddy et al., 1978 ) also found delayed equilibration in patients with chronic bronchitis. Therefore, the effect of basing an estimate of exchangeable potassium on samples taken at around 24 hours may well underestimate the true value of body potassium. Only three studies have so far been reported in which the total body potassium of patients in cardiac failure has been measured by counting 40K in a whole body counter. The deficits of body potassium content were reported as being 10 per cent by Delwaide and Rorive (1973) ; 5 per cent by Davidson et al. (1976); and Lawson et al. (1976) (Rundo and Sagild, 1955; Talso et al., 1960; Surveyor and Hughes, 1968) . Only one study has investigated this ratio in healthy elderly subjects where it was found to be 92 per cent (Lye et al., 1976) .
Patients and methods
Eleven male and 11 female patients were investigated in this study. Clinically, the patients' cardiac condition was stable and antiheart failure treatment had been unchanged for a period of at least two months before our measurements. All patients were free from oedema at the time of study. Eighteen patients were taking both diuretics and digoxin, three of the 18 were taking thiazide diuretics, while the remainder were taking frusemide (40 to 80 mg); two patients were taking frusemide only; one patient was taking digoxin only, and one patient was not on specific antiheart failure treatment. All patients taking diuretics were also given potassium supplements (7 7 to 48-4 mmol/24 h). Details of the patients studied are given in Table 1 . Whole body potassium was measured using a Nuclear Enterprises shadow shield monitor to detect the naturally occurring 1-47 MeV gamma rays emitted by 40K. The detectors are four NaI (TI) crystals, each 152 x 102 mm, two placed above and two placed below the motorised couch. The patient lay supine on the couch which then passed between the detectors, making a complete pass in both directions and the counts were accumulated for a total time of 45 minutes. Each patient was individually calibrated to take account of the attenuation of the gamma rays within the body, using the following method. The coefficient of variation, which is inversely related to the patient 40K count, of the results obtained by this technique with the present apparatus had a mean value of 4f6 per cent, with a range of 3-2 to 6-7 per cent. We believe that the direct calibration method is more accurate than calculation of a calibration factor based on height and weight (Boddy et al., 1972a The patients were all in hospital at the time of the study and the urine collections were supervised by a research nurse. Patients with incontinence or intermittent confusion were excluded. We are therefore satisfied that most urine collections were complete. In the known cases of incomplete collection, an average value of 96-3 per cent retention was assumed.
Results
The data obtained from the 22 patients are shown in Table 2 . The mean whole body potassium of all TeK48 and whole body potassium than between TeK24 and whole body potassium (r=0-86).
A number of patients, not unexpectedly in view of their chronic cardiac failure, had evidence of impaired renal function. The mean blood urea was 8 ±5 mmol/l, with a range of 5 to 23 mmol/l. There were five patients (three women) whose blood urea was 10 mmol/l or more. The mean creatinine clearance was 56 ±37 ml/min with a exchangeable potassium measured at 24 hours (TeK24)
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The fact that total exchangeable potassium increased significantly during the second 24-hour period leads us to believe that equilibration times are increased in the present group of subjects and confirms the findings of earlier reports on patients with cardiac failure. Where body potassium has been estimated from measurements of total exchangeable potassium, it has been suggested that body potassium is significantly reduced (Davidson and Gillebrand, 1973; Nicholls et al., 1976; British Medical Journal, 1977) . However, where whole body potassium has been measured by whole body counting, little or no deficit has been found (Delwaide and Rorive, 1973; Davidson et al., 1976; Lawson et al., 1976) . The present study confirms that, for patients with cardiac failure, the quantification ofthe degree ofpotassium depletion by measuring total exchangeable potassium may well exaggerate the degree of depletion, and caution should be exercised in basing any treatment regimen on such tests. 
